D.A. Davidson & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-19,549
| Closed | -$406K | – | 1091 |
|
2018
Q3 | $406K | Sell |
19,549
-13,300
| -40% | -$276K | 0.01% | 792 |
|
2018
Q2 | $502K | Buy |
32,849
+3,150
| +11% | +$48.1K | 0.01% | 700 |
|
2018
Q1 | $667K | Buy |
29,699
+100
| +0.3% | +$2.25K | 0.01% | 595 |
|
2017
Q4 | $891K | Buy |
29,599
+1,508
| +5% | +$45.4K | 0.02% | 491 |
|
2017
Q3 | $1.06M | Buy |
28,091
+900
| +3% | +$33.9K | 0.02% | 493 |
|
2017
Q2 | $758K | Sell |
27,191
-1,900
| -7% | -$53K | 0.02% | 513 |
|
2017
Q1 | $1M | Buy |
29,091
+641
| +2% | +$22K | 0.02% | 442 |
|
2016
Q4 | $820K | Buy |
+28,450
| New | +$820K | 0.02% | 511 |
|
2016
Q3 | – | Sell |
-500
| Closed | -$16K | – | 2366 |
|
2016
Q2 | $16K | Hold |
500
| – | – | ﹤0.01% | 1821 |
|
2016
Q1 | $13K | Buy |
+500
| New | +$13K | ﹤0.01% | 1833 |
|